Homepage
Author:
Bluejay Diagnostics, Inc.
Posted Date:
June 5, 2026
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Bluejay Diagnostics, Inc.
June 5, 2026
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Bluejay Diagnostics, Inc.
June 2, 2026
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics, Inc.
June 2, 2026
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
Bluejay Diagnostics, Inc.
May 7, 2026
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
Bluejay Diagnostics, Inc.
April 7, 2026
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
Bluejay Diagnostics, Inc.
March 12, 2026
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook
Bluejay Diagnostics, Inc.
March 6, 2026
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised
Bluejay Diagnostics, Inc.
February 20, 2026
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026
Bluejay Diagnostics, Inc.
February 17, 2026
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Bluejay Diagnostics, Inc.
January 28, 2026
